Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Mar-Apr;50(2):115–125. doi: 10.1590/0100-3984.2015.0140

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

HCC evaluated using gadoxetate disodium (hepatobiliary contrast agent). Axial fat-suppressed (A) SS-FSE T2-WI, axial pre- (B) and postgadolinium (gadoxetate disodium) fat-suppressed 3D-GRE T1-WI in the arterial (C), interstitial (D) and hepatobiliary phases (E). An HCC is depicted in the right liver lobe, in a background cirrhotic parenchyma, showing mild high signal intensity on T2-WI, low signal intensity on T1-WI, hypervascular characteristics (C) and washout on the delayed phase (D). On the hepatobiliary phase, due to the presence of impaired hepatocytes, the HCC shows no enhancement (E). Note the enhancement of the biliary duct (arrowheads, E).